Small interfering RNAs (siRNAs) are now established as a favourite tool to reduce gene expression by RNA interference (RNAi) in mammalian cell culture. However, limitations in potency, duration, delivery and specificity of the gene knockdown (KD) are still major obstacles that need further addressing. Recent studies have successfully improved siRNA performance by the introduction of several types of chemical modifications. Here we explore the effect of incorporating unlocked nucleic acid (UNA) into siRNA designs. The acyclic UNA monomers lack the C2 0 -C3 0 -bond of the RNA ribose ring and additively decrease nucleic acid duplex thermostability. We show that UNA-modifications of siRNAs are compatible with efficient RNAi and can improve siRNA performance both in vitro and in vivo. In particular, we find that the destabilizing properties of UNA are well suited to enhance the potency of siRNAs which are heavily modified by other chemical modifications such as locked nucleic acid (LNA), C4 0 hydroxymethyl-DNA (HM), 2 0 -O-methyl-RNA (OMe), DNA and 2 0 -Flouro-DNA (F).
Introduction
The use of siRNA to knock down gene function has truly revolutionized mammalian cell cultures studies and holds great promise in therapeutics. [1] [2] [3] Several siRNA designs have been suggested, 4 ,5 yet most studies utilizes a standard siRNA design comprising a 21 base pair (bp) RNA duplex containing a 19mer base pairing stem and 2 nucleotide (nt) 3 0 overhangs. 6 Upon introduction into the cell cytoplasm siRNAs are taken up into the RNA-induced silencing complex (RISC), the nonguiding sense strand (SS) is degraded and the guiding antisense strand (AS) will subsequently direct the sequence-specific cleavage of perfectly complementary RNAs. [7] [8] [9] [10] [11] [12] [13] In spite of the great potency and applicability of siRNAs, a number of obstacles still hamper their wider use. Most prominent is the current lack of efficient means of siRNA delivery under the harsh condition in vivo where naked siRNA are quickly degraded by extra-and intracellular ribonucleases. 14, 15 Other concerns are reports of poor KD specificity as siRNAs can both induce innate immune responses 16 and exert broad off-target effects on non-intended targets sharing only partial sequence complementarity with the siRNA. 17, 18 To address these problem we and others have successfully modified siRNAs and identified highly active, more nuclease resistant and target-specific siRNAs. 5, 14, 15, [19] [20] [21] [22] [23] [24] Recently, a large scale comparison of 21 types of chemical modifications in siRNA design found unlocked nucleic acid (UNA) to have several interesting properties. 23 UNA monomers are acyclic derivatives of RNA lacking the C2 0 -C3 0 -bond of the RNA ribose ring, yet still structurally mimicking unmodified RNA upon incorporation into RNA duplexes. Incorporation of UNA monomers into siRNAs induces additive instability by 5-8 1C per UNA monomer thereby providing a unique possibility to locally destabilize the siRNA duplex. 25 Here we extend our analysis of incorporating UNA into siRNA designs and show how UNA can be utilized to improve siRNA performance. We find that low levels of UNA modifications in siRNAs are compatible with efficient RNAi whereas more extensive UNA modification lowers siRNA efficiency and serum stability. Yet, even low levels of UNA modification can be highly beneficial; especially the strong destabilizing property of UNA can be strategically used both in the SS and AS to significantly improve the potency of extensively modified siRNAs that are otherwise too stable or rigid to support RNAi. Interestingly, lightly UNA-modified siRNA has prolonged biostability in vivo, even compared to extensively LNA modified siRNA, and produces efficient gene KD in a mouse model bearing human pancreas tumour xenografts. Hereby, UNA constitutes an important type of siRNA modification that has several interesting properties for siRNA function both in vitro and in vivo.
Results and discussion
Tolerance for UNA-modification in the SS To investigate the impact of UNA-modification on siRNA activity we generated a H1299 cell line stably expressing a dual luciferase reporter harbouring a single perfect eGFP target site within the renilla luciferase 3 0 UTR. This cell line was transfected with chemically modified siRNAs at either 1 or 10 nM concentration (final concentration in the medium) using the Lipofectamine 2000 transfection reagent and the relative KD of renilla luciferase activity was evaluated 48 h after transfection (see Table 1 for an overview of the chemically modified ASs and SSs). We initially tested the tolerance for UNA modification at various positions within the SS or AS in combination with an unmodified opposing strand ( Fig. 1A and 1B, respectively and see Fig. 1E for a structural representation of UNA). As reported for many other chemistries 5 we find that single UNA modifications are well tolerated in the SS 3 0 overhang (W131) and additionally also in the SS 5 0 end (W132), central region (W308), 3 0 end (ID1276; Fig. 1A ). Also triple UNA-modifications alone (W282) or in combination with 5 0 end LNA modification (W321) only reduced siRNA potency slightly as compared to the unmodified siRNA against eGFP, denoted siEGFP (Fig. 1A) .
Tolerance for UNA-modification in the AS
We found that UNA-modification of the central part of the siRNA AS (W320, W126), 3 0 end (W125) and overhang (W127) are well tolerated, whereas UNA-modification of the AS seed region (position 2-8 of counting from the 5 0 end) can lead to slightly reduced potency (W315, W317, W318; Fig. 1B ). Also double and triple modifications within the base-pairing stem of the siRNA duplex (W329, W187, W281 and W186) resulted in reduced silencing efficiency (Fig. 1B) . Since these ASs efficiently form siRNA duplexes upon annealing to the unmodified SS, W207 (Fig. 4A) we speculate that several UNA-modifications may excessively destabilize AS interactions with the target site.
Tolerance for UNA-modification of siRNA duplexes
We next combined the functional UNA-modified SSs and ASs to test the tolerance for simultaneous UNA-modification in both siRNA strands (Fig. 1C) . As expected, siRNA efficiency was largely dependent on the activity of the UNA-modified AS; all single-modified ASs retained their high silencing activity in combination with all tested SSs irrespectively of the positioning of the UNA modifications within the AS and SS (see all combinations of ASs W317, W126, W125 with SSs W132, W308, ID1278, W282; Fig. 1C ). The activity of the double and triple UNA-modified ASs (W329, W187 and W186, respectively) were more sensitive to SS modification; in particular the silencing activity of these ASs declined in combination with the double UNA-modified SS, W282 (Fig. 1C) . This reduction in silencing potency for extensively UNA-modified siRNAs may well be due to excessive thermodynamic destabilization of the siRNA duplex and indeed we were largely unable to anneal several of the highly modified siRNAs (such as W281-W308, W330-W282 and W281-W282; Fig. 4A ). We therefore recommend not to incorporate more than two UNA modifications in total within the base-paring siRNA stem unless the siRNA is stabilized by other types of chemical modifications (see below).
Combining UNA and LNA allow higher levels of siRNA modification
As incorporation of more than one UNA modification into the AS resulted in reduced silencing (W329, W187, W186, W281; Fig. 1B ) and reduced serum stability (Fig. 4A) , we speculated that their potency may be enhanced in combination with a stabilizing, LNA-modified SS, W037. LNA monomers additively increase thermal stability by 2-10 1C per modification 26 and thereby counteract siRNA destabilization by UNA. We have previously reported that the activity of 36 out of 48 chemically modified ASs was reduced in combination with the LNA modified SS, W037, as compared to an unmodified SS, W207, and we never found any improvement in AS potency by W037. 23 Similarly, the potency of the unmodified AS (W053) is significantly reduced in combination with the LNA modified SS, W037 as compared to the unmodified SS, W207 (Fig. 3A) . Here we found that the activity of both UNA modified AS, W329 and W187, was even enhanced in combination with W037 ( Fig. 1D ) and that the stability was greatly increased (stability is shown for W329 in Fig. 4B , data not shown for W187). This shows that balancing the use of the strongly stabilizing LNA and the destabilizing UNA can allow higher levels of siRNA modification and thereby enhance siRNA stability without compromising silencing efficiency.
UNA-modification of SS 3
0 end enhance siRNA performance
As strand selection during RISC loading is dependent on the thermodynamic profile of the siRNA duplex 27, 28 we speculated that UNA destabilization of the SS 3 0 end may enhance AS selection and thereby siRNA performance. To test this we generated a set of six ASs having single LNA-modifications at position 1-6 from the 5 0 end. As LNA-modifications are strongly stabilizing this generates a series of siRNA with a highly asymmetric thermodynamic profile unfavourable for AS incorporation into RISC. We found that UNA-modification at the 3 0 double stranded end of the SS (ID1276) did indeed improve the performance of siRNAs having LNAmodifications at positions 1-3 of the AS whereas no effect was seen for ASs modified at pos. 4-6 ( Fig. 2A ). This is in good agreement with previous studies showing that strand selection is primarily determined by the thermodynamic profile of the outermost positions of the stem. 27, 28 We next asked if UNA-modification of the SS 3 0 end may also improve the performance of more heavily modified ASs containing several LNA (W209) or HM (JW1187) modifications (See Table 1 ). Again we found that two 3 0 end UNA modified SSs (ID1276, ID1277) indeed enhanced the performance of LNA-(W209) and HM-modified (JW1187) ASs to similar level as siEGFP (Fig. 2B) . Furthermore, we did not observe any significant decrease in siRNA serum stability upon incorporation of UNA in the SS 3 0 end when using the LNA-modified AS, W209 (compare W209-W207 with W209-ID1276; Fig. 4B ).
UNA-modification can shift siRNA strand selection
To investigate if strand selection during RISC loading is altered by UNA modification of the SS 3 0 end we investigated the silencing efficiency of the SSs ID1276 and W131 in combination with the ASs modified by LNA at pos. 1, pos. 2, extensive LNA (W010) or HM (JW1187) using both the AS sensor and a luciferase sensor containing a perfect target site for the SS sequence (SS sensor). We found that the silencing activity of ID1276 is significantly reduced as compared to W131 for all tested ASs whereas AS performance is improved (Fig. 2C ). This strongly suggests that SS 3 0 end UNA-modification does indeed disfavour SS and thereby favour AS incorporation during RISC loading.
UNA-modification of the SS enhance the activity of heavily modified siRNA duplexes
We have previously reported that the so-called sisiRNA design characterized by a segmented LNA-modified SS enhances the potency of heavily modified siRNA likely by destabilizing or introducing flexibility into the siRNA duplex. 5 Therefore, we speculated that thermodynamic destabilization imposed by the UNA modification would similarly introduce flexibility into extensive modified siRNAs and thereby enhance their potency. To test this we introduced two UNA-modifications into a heavily LNA-modified SS (compare W037 and NAC3168) and tested its impact on silencing in combinations with AS modified by OMe (Dharm1), alternating OMe/F (JC10), HM (JW1187) and LNA (W010) (see Table 1 ). Indeed we found that both the UNA-modified SS (NAC3168) and sisiRNA design (W004+W179) enhanced the potency of most ASs (Dharm1, JC10, HM1187 and unmodified AS (W053) to levels comparable to the unmodified SS (W207; Fig. 3 ). Only the heavily LNA-modified AS (W010) were significantly more efficient in combination with the sisiRNA design (W004+W179) as compared to the UNA/LNA-modified SS (NAC3168), yet the silencing efficiency was still significantly improved by NAC3168 to levels indistinguishable from the unmodified SS, W207 (Fig. 3A) . This shows that UNAmodification of the SS may be utilized in extensively modified siRNA designs to enhance silencing activities.
UNA-modification of the AS can enhance the potency of heavily modified siRNA duplexes
We next asked if UNA modifications could similarly be incorporated into ASs to enhance siRNA performance, especially of the heavily LNA-modified duplexes. To test this we inserted a central UNA modification into a heavily LNA-modified AS (W188) and combined these with the heavily LNA-modified SSs, W037 and W013. We found that the introduction of UNA-modification in the central part of AS did indeed enhance the efficiency of the siRNA duplexes for both LNA-modified SSs, W037 and W013 as compared to the LNA-modified AS without UNA (W010) (Fig. 3B) . Furthermore, we generated two SSs fully substituted with mixed DNA and LNA modifications (W008, W009) and tested these in combination with an AS containing a central UNA modification, W126 (Fig. 3C) . Again we found a higher performance of W126 as compared to the unmodified AS, W053. Collectively, this clearly demonstrates that a UNA-modification of both the SS and ASs can significantly help increasing the number of total modifications that are tolerated in siRNA designs.
The impact of UNA modification on siRNA biostability in vitro As UNA modification decreases siRNA thermodynamic stability, 25 we next investigated the impact of UNA modification on siRNA biostability in vitro (Fig. 4A&B ) and upon injection of naked siRNAs in mice (Fig. 5A&B) . Notably, we were unable to anneal the most heavily UNA-modified siRNA duplexes such as W330-W282, W281-W282 and W281-W308 (Fig. 4A) suggesting that care must be taken when incorporating more than two UNA-modifications into the stem of siRNAs. Furthermore all investigated siRNAs modified exclusively by UNA within the stem had significantly reduced stability and were largely degraded after 5 min of incubation in 80% FCS (Fig. 4A) . We therefore recommend the use of shielding delivery reagents when utilizing siRNA modified only by UNA within the base pairing stem. In contrast, insertion of UNA into the stem of very extensively modified siRNA such as OMe/F/UNA-modified and LNA-modified duplexes did not significantly reduce serum stability (compare JC10-W037 to JC10-NAC3168 and W209-ID1276 to W209-W207, respectively; Fig. 4B) . Furthermore, the incorporation of UNA in either the SS or AS of extensively LNA-modified siRNA only marginally reduced siRNA serum stability (compare W010-NAC3168 and W188-W037 to W010-W037; Fig. 4B ) although siRNA potency was significantly enhanced (Fig. 3) .
The impact of UNA modification on siRNA biostability and knock down efficiency in vivo
We have previously observed that extensive LNA-stabilization can prolong the blood circulation time of naked siRNA in 29 and mediate efficient KD of eGFP in the lungs. 30 Very surprisingly, siRNA modified with UNA only in the AS and SS overhangs, W127-W131, exhibited an even prolonged blood circulation time with siRNA species detectable 24 h after injection in blood and several organs such as kidney, spleen lung and hearth (Fig. 5A & B) . This was unexpected as W127-W131 is only marginally more stable than unmodified siRNA upon incubation in 80% FCS (Fig. 4B) . However, W127-W131 did exhibit surprisingly high stability upon incubation in freshly prepared mouse serum (Fig. 4B) . This suggests that the composition of nuclease differs between FCS and mouse serum with the latter having relatively less riboendonuclease activity. The result also underscores the necessity of testing siRNA stability in the biological fluids relevant to the particular siRNA application. Next we tested the potential of UNA modifications to enhance siRNA function in vivo. Notably, we observed a potent eGFP KD in a mice model bearing human eGFP-expressing pancreas tumor xenografts upon subcutaneous injection of the naked UNAmodified siRNA, W127-W131, whereas no effect was observed using non-modified siRNA. This demonstrates that the UNA-modified siRNA duplex was indeed biological functional and superior to unmodified siRNA (Fig. 5C ) and hereby establishes UNA as an important type of chemical modification with great potential in siRNA therapeutics.
Experimental Preparation of siRNA duplexes
The phosphoramidites were incorporated into the siRNA sequence through solid-phase DNA/RNA synthesis on an automated DNA/RNA synthesizer using O2 0 -TBDMS protected RNA phosphoramidites and common reagents as described in ref. 23 (for structures of chemically modified nucleotide monomers, see Fig. 1E ). The oligoes are named according to the nomenclature of previously published work to allow easy comparison of results between individual studies. For siRNA annealing SS and AS were mixed in 1x Dharmacon annealing buffer (Dharmacom) and incubated at 95 1C for 1 min and 1 h at 37 1C and siRNA concentration was quantified using the Quant-iT RiboGreen RNA Assay Kit from Molecular Probes (Invitrogen) on a FLUOstar luminometer (BMG labtech).
Cell culture, transfections and Dual-luciferase assay
The human lung cancer cell line H1299 was grown in RPMI-1640 containing 10% FBS, 1% penicillin/streptomycin. A stable luciferase reporter H1299 cell line was created by transfection and subsequent pyromycin selection (1 mg ml À1 medium) of H1299 cells with a psiCHECK2 vector (Promega) modified to contain a perfect target site for eGFP in the multiple cloning site (MCS) and a pyromycin selection cassette. siRNA transfections were performed in triplicates using the Lipofectamine 2000 reagent (Invitrogen) in a 96 well format using 15.000 cells in 100 ml serum-free RPMI. Growth medium was added 4 h after transfection and cell lysates were harvested after 48 h and dual-luciferase assays were performed using the 'Dual-luciferase reporter assay system' (Promega) according to the manufacturer's protocol on a FLUOstar luminometer (BMG labtech); renilla luciferase signals (sample) were normalized to the firefly luciferase signals (transfection control). Transient transfection experiments using the reporter constructs pISO-AS-target and pISO-SStarget to evaluate AS and SS efficiency (Fig. 2C) is described previously. 5 Evaluation of siRNA serum stability Annealed UNA/LNA-modified siRNAs were incubated at 37 1C in 80% fetal calf serum (FCS) or 80% freshly prepared mouse serum. Aliquots of 5 ml (each containing 20 pmol of siRNA) were diluted in 25 ml 1.2ÂTBE loading buffer (1.2ÂTBE, 10% glycerol, bromphenol blue) and snap-frozen on dry ice immediately upon sample taking. Samples were run on a 15% native polyacrylamide gel and stained using SYBR Gold s (Invitrogen).
Biostability of siRNAs in mice
For investigation of siRNA biostability and biodistribution in mice 10 mg unmodified, LNA-or UNA-modified siRNA duplex was administered i.v. in a total volume of 200 ml. Total RNA was purified by Trizol reagent (Invitrogen, Carlsbad, CA) from frozen blood samples and weighed tissue in RNAlater (Ambion). RNA from blood (2 mg) and from tissues (4 mg) was run on 15% denaturing polyacrylamide gels and transferred onto Hybond-N+ membrane (Amersham Biosciences, Uppsala, Sweden). After UV crosslinking, the membranes were analyzed on a phophorimager to visualize the 32 P labelled AS of the siRNA. To perform northern blotting, the same In vivo efficacy of siRNAs in human xenograft liver cancer model in mice siRNA was tested for its ability to repress EGFP expression in vivo. Subcutaneous tumours were induced in 8-to 10-weekold NMRI nu/nu mice (Charles River, Maastricht, the Netherlands) by injection of 10 6 MiaPaca II tumour cells in Matrigel (BD Biosciences). One week after tumour cell injection, when tumour take was positive, administration of the siRNA started. Administration was via osmotic minipumps (model 1007D; Alzet Corp., Palo Alto,CA) placed subcutaneously. Total RNA was isolated from the tumours and livers and EGFP mRNA levels were determined in these samples by Northern blotting.
Conclusion
Our current and previous work has identified UNA as an important modification in siRNA design. We have previously reported that UNA-modification of the SS 3 0 overhang can enhance siRNA potency and that UNA modification of ASs could enhance target cell viability. 5 Recently we have also found that UNA-modification of the AS seed region can reduce off-target effects (Bramsen et al., in prep.). Here we have extended our analysis of UNA-modification in siRNA design and describe novel strategies to improve siRNA performance. We find that single UNA modifications are well tolerated at most tested positions in the AS and SS; However, additional UNA-modifications, especially in the AS, lead to reduced silencing efficiency (Fig. 1A-C) likely by destabilizing the siRNA duplex or interactions with the target mRNA. In accordance, UNA-modification of the siRNA stem often lead to reduction in serum stability and siRNA duplexes with several UNA-modifications are not efficiently formed under standard siRNA annealing conditions (Fig. 4A ). Yet, we find that even few UNA-modifications can significantly improve siRNA performance if placed strategically within the siRNA duplex; introduction of UNA in the 3 0 end of the SS can enhance siRNA efficiency of thermodynamically asymmetric siRNA by favoring AS incorporation into RISC (Fig. 2) . Furthermore, UNA modification seems well suited in siRNA designs in combination with stabilizing modifications such as e.g. LNA to enhance siRNA potency: Incorporation of UNA into an extensively LNA-modified SS enhanced the potency of ASs containing several types of chemical modifications (Fig. 3) . Similarly, inserting UNA into both unmodified and extensively LNA-modified ASs enhanced siRNA potency in combination with several extensively modified SS (Fig. 3) . Notably, introduction of UNA into the stem of extensively modified siRNA did not dramatically reduce serum stability in . 5A ) and the siRNA levels were quantified and normalized to total RNA harvested from the specific organ. Experiments were performed in duplicates and M1 and M2 denoted the two mice used for the experiment. C. Efficiency in eGFP KD by UNA-modified siRNAs in a human pancreas cancer xenograft model in mice. siEGFP is an unmodified siRNA duplex containing the AS W053 and SS W207. siEGFPmis is a mismatch control.
contrast to siRNAs modified exclusively with UNA (Fig. 4B) . Thus, UNA can be used to improve the KD efficiency of heavily modified siRNA without necessarily hampering the stability of the duplex. Interestingly, we find a prolonged survival of siRNA modified by UNA in their 3 0 overhangs upon intravenous injection in mice even when compared to extensively LNA-stabilized siRNAs (Fig. 5) . Moreover, these UNA-modified siRNAs are biologically active leading to >50% KD of eGFP expression in a pancreas tumor xenograft model in mice in contrast to unmodified siRNAs. Collectively, this makes the UNA modification a potent chemical modification for increasing efficiency, stability and specificity of siRNAs with great potential in therapeutics.
